These factors assist in maintaining immune homeostasis and safeguarding against autoimmunity; however, using PD‐1, PD‐L1, or CTLA‐4 monoclonal antibodies can be useful in upregulating T‐cell response against tumor cells. This evidence concerns the gene CTLA4 and neoplasm.